https://stock.noler.com/us/stock/arena-pharmaceuticals-inc https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/accounts-payable https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/accounts-payable-and-other-accrued-liabilities-current https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/accounts-payable-other-current-and-noncurrent https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/accounts-receivable https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/accrued-liabilities-current https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/accumulated-depreciation https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/additional-paid-in-capital https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/allowance-for-doubtful-accounts-receivable-write-offs https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/amended-reports-10-k https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/amortization https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/amortization-of-financing-costs https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/amortization-of-financing-costs-and-discounts https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/aoci https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/area-of-real-estate-property https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/assets-fair-value-disclosure https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/assets-of-disposal-group-including-discontinued-operation https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/assets-of-disposal-group-including-discontinued-operation-current https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/available-for-sale-current https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/available-for-sale-debt-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/available-for-sale-debt-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/available-for-sale-debt-current https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/available-for-sale-debt-noncurrent https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/available-for-sale-debt-securities https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/available-for-sale-gross-realized-gain-loss-net https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/available-for-sale-gross-realized-gains https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/available-for-sale-gross-unrealized-gain-loss https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/available-for-sale-gross-unrealized-gain-loss-1 https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/available-for-sale-gross-unrealized-loss https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/available-for-sale-noncurrent https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/basic-shares https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/capital-expenditures https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/capital-lease-obligations https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/capital-lease-obligations-current https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/capital-lease-obligations-noncurrent https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/capital-leases-future-minimum-payments-due https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/capital-leases-future-minimum-payments-due-current https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/capital-leases-future-minimum-payments-due-in-five-years https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/capital-leases-future-minimum-payments-due-in-four-years https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/capital-leases-future-minimum-payments-due-in-three-years https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/capital-leases-future-minimum-payments-due-in-two-years https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/capital-leases-future-minimum-payments-due-thereafter https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/capital-leases-future-minimum-payments-interest-included-in-payments https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/capital-leases-income-statement-interest-expense https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/cash-and-cash-equivalents-at-carrying-value-including-discontinued-operations https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/cash-and-cash-equivalents-fair-value-disclosure https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/cash-and-equivalents https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/cash-and-restricted-cash-including-disposal-group-and-discontinued-operations https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/cash-cash-equivalents-and-short-term-investments https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/cash-divested-from-deconsolidation https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/cash-flow-breakdown https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/cash-provided-by-used-in-investing-activities-discontinued-operations https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/cash-provided-by-used-in-operating-activities-discontinued-operations https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights-1 https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/common-stock-value https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/comprehensive-income https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/comprehensive-income-net-of-tax-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/comprehensive-income-net-of-tax-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/contract-with-customer-asset-net https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/contract-with-customer-asset-net-current https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/contract-with-customer-asset-net-noncurrent https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/conversion-of-stock-amount-converted https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/cost-of-goods-sold https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/cost-of-services https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/costs-and-expenses https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/current-assets https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/current-liabilities https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/debt-decrease-repayments https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/debt-fair-value https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/debt-increase-additional-borrowings https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/debt-unused-borrowing-capacity-amount https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/deconsolidation-gain-or-loss-amount https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/deferred-rent-credit-noncurrent https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/deferred-revenue https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/deferred-revenue-noncurrent https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/deferred-revenue-recognized https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/deferred-tax-assets-in-process-research-and-development https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/deferred-tax-assets-liabilities-net-noncurrent https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards-domestic https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards-foreign https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/deferred-tax-assets-tax-deferred-expense-other https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/deferred-tax-liabilities https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/deferred-tax-liabilities-investments https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/defined-benefit-plan-contributions-by-employer https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/defined-contribution-plan-cost-recognized https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/defined-contribution-plan-employer-matching-contribution-percent https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/defined-contribution-plan-employer-matching-contribution-percent-of-match https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/defined-contribution-plan-maximum-annual-contribution-per-employee-percent https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/deposits-assets-noncurrent https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/depreciation-and-amortization https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/derivative-assets-liabilities-at-fair-value-net https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/derivative-financial-instruments-liabilities-fair-value-disclosure https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/derivative-liabilities https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/derivative-liabilities-current https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/derivative-liabilities-noncurrent https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/diluted-shares https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/discontinued-operation-gain-loss-on-disposal-of-discontinued-operation-net-of-tax https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/discontinued-operation-income-loss-from-discontinued-operation-before-income-tax https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/discontinued-operation-income-loss-from-discontinued-operation-net-of-tax-per-basic-and-diluted-share https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/discontinued-operation-income-loss-from-discontinued-operation-net-of-tax-per-basic-share https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/discontinued-operation-income-loss-from-discontinued-operation-net-of-tax-per-diluted-share https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/disposal-group-including-discontinued-operation-accounts-notes-and-loans-receivable-net https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/disposal-group-including-discontinued-operation-accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/disposal-group-including-discontinued-operation-assets-noncurrent https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/disposal-group-including-discontinued-operation-costs-of-goods-sold https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/disposal-group-including-discontinued-operation-deferred-revenue-current https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/disposal-group-including-discontinued-operation-general-and-administrative-expense https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/disposal-group-including-discontinued-operation-intangible-assets-current https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/disposal-group-including-discontinued-operation-intangible-assets-noncurrent https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/disposal-group-including-discontinued-operation-inventory-current https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/disposal-group-including-discontinued-operation-operating-expense https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/disposal-group-including-discontinued-operation-operating-income-loss https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/disposal-group-including-discontinued-operation-other-expense https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/disposal-group-including-discontinued-operation-other-noncurrent-assets https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/disposal-group-including-discontinued-operation-prepaid-and-other-assets-current https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/disposal-group-including-discontinued-operation-property-plant-and-equipment-current https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/disposal-group-including-discontinued-operation-revenue https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/effect-of-exchange-rate-on-cash-and-cash-equivalents https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/embedded-derivative-fair-value-of-embedded-derivative-liability https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/eps https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/eps-basic https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/fair-value-assumptions-weighted-average-volatility-rate https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/finance-lease-liability-payments-due https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/finance-lease-liability-payments-due-after-year-five https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/finance-lease-liability-payments-due-next-twelve-months https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/finance-lease-liability-payments-due-year-five https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/finance-lease-liability-payments-due-year-four https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/finance-lease-liability-payments-due-year-three https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/finance-lease-liability-payments-due-year-two https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/finance-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/finance-lease-principal-payments https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/financing-cash-flow https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-next-rolling-twelve-months https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-rolling-after-year-five https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-rolling-year-five https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-rolling-year-four https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-rolling-year-three https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-rolling-year-two https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/foreign-earnings https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/foreign-earnings-repatriated https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/foreign-pretax-income https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/form-d-other https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/form-d-stocks https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/gain-loss-on-sale-of-previously-unissued-stock-by-subsidiary-or-equity-investee-nonoperating-income https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/general-and-administrative-expense https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/impairment-of-investments https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/income-loss-attributable-to-parent https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/income-loss-from https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/income-loss-from-discontinued-operations-net-of-tax https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/income-loss-from-discontinued-operations-net-of-tax-attributable-to-reporting-entity https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/income-loss-from-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/income-loss-from-per-basic-and-diluted-share https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/income-loss-from-per-basic-share https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/income-loss-from-per-diluted-share https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/income-tax https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/increase-decrease-in-contract-with-customer-liability https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/increase-decrease-in-deferred-liabilities https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/increase-decrease-in-other-noncurrent-liabilities https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/interest-expense https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/interest-expense-on-debt https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/interest-paid-net https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/interest-portion-of-minimum-lease-payments-sale-leaseback-transactions https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/inventory https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/inventory-finished-goods https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/inventory-finished-goods-net-of-reserves https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/inventory-raw-materials https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/inventory-raw-materials-net-of-reserves https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/inventory-recall-expense https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/inventory-work-in-process https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/inventory-work-in-process-net-of-reserves https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/investing-cash-flow https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/investment-income-amortization-of-premium https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/investment-income-interest https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/lease-and-rental-expense https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/lessor-operating-lease-payments-to-be-received https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/lessor-operating-lease-payments-to-be-received-five-years https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/lessor-operating-lease-payments-to-be-received-four-years https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/lessor-operating-lease-payments-to-be-received-next-twelve-months https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/lessor-operating-lease-payments-to-be-received-thereafter https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/lessor-operating-lease-payments-to-be-received-three-years https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/lessor-operating-lease-payments-to-be-received-two-years https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/liabilities-of-disposal-group-including-discontinued-operation-current https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/litigation-reserve-current https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/litigation-settlement-expense https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/minimum-lease-payments-sale-leaseback-transactions https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/minimum-lease-payments-sale-leaseback-transactions-thereafter https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/minimum-lease-payments-sale-leaseback-transactions-within-five-years https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/minimum-lease-payments-sale-leaseback-transactions-within-four-years https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/minimum-lease-payments-sale-leaseback-transactions-within-one-year https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/minimum-lease-payments-sale-leaseback-transactions-within-three-years https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/minimum-lease-payments-sale-leaseback-transactions-within-two-years https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/multiemployer-plan-contributions-by-employer https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/multiemployer-plan-period-contributions https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/net-change-in-cash https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/net-income https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/net-income-loss-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/new-accounting-pronouncement-or-change-in-accounting-principle-effect-of-adoption-quantification https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/noncontrolling-interest-decrease-from-deconsolidation https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/noncontrolling-interest-in-variable-interest-entity https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/number-of-operating-segments https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/number-of-reportable-segments https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/oci-available-for-sale-adjustment-before-tax https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/oci-available-for-sale-adjustment-net-of-tax https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax-2 https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/oci-foreign-currency-transaction-and-translation-gain-loss-arising-net-of-tax https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/oci-net-of-tax-change https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/oci-reclassification-adjustment-from-aoci-for-sale-of-securities-net-of-tax https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/operating-cash-flow https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/operating-costs-and-expenses https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/operating-income https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/operating-lease-assets https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/operating-lease-expense https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/operating-lease-liability https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/operating-lease-liability-current https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/operating-lease-payments-due https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/operating-leases-rent-expense-sublease-rentals https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/other-income https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/other-noncurrent-assets https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/other-operating-activities-cash-flow-statement https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/paid-in-capital-share-based-compensation-other-longterm-incentive-plans-requisite-service-period-recognition https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/payments-for-proceeds-from-other-investing-activities https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/payments-for-restructuring https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/payments-to-acquire-available-for-sale-debt https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/payments-to-acquire-available-for-sale-securities https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/payments-to-acquire-in-process-research-and-development https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/payments-to-acquire-productive-assets https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/postconfirmation-preferred-and-common-stock-held-in-treasury https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/preferred-shares-facts https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/preferred-stock-dividends-and-other-adjustments https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/preferred-stock-value https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/pretax-income https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/pretax-income-domestic https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/proceeds-from-collaborators https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/proceeds-from-issuance-of-debt https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/proceeds-from-issuance-of-preferred-stock-and-preference-stock https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/proceeds-from-issuance-of-shares-under-incentive-and-share-based-compensation-plans-including-stock-options https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/proceeds-from-long-term-capital-lease-obligations https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/proceeds-from-payments-for-other-financing-activities https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/proceeds-from-sale-and-maturity-of-available-for-sale-securities https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/proceeds-from-sale-maturity-and-collection-of-shortterm-investments https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/proceeds-from-sale-of-available-for-sale-securities https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/proceeds-from-sale-of-machinery-and-equipment https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/profit-loss https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/property-plant-equipment https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/property-subject-to-or-available-for-operating-lease-number-of-units https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/provision-for-loss-on-contracts https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/public-float https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/receivable-current https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/repayments-of-long-term-capital-lease-obligations https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/repayments-of-notes-payable https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/research-and-development https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/research-and-development-expense-excluding-acquired-in-process-cost https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/research-and-development-in-process https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/residual-value-of-leased-asset https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/restricted-cash https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/restructuring-and-related-cost-expected-number-of-positions-eliminated https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/restructuring-and-related-cost-number-of-positions-eliminated-period-percent https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/restructuring-charges https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/restructuring-reserve https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/restructuring-reserve-current https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/retained-earnings https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/revenue https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/revenue-from-contract-with-customer-excluding-assessed-tax https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/revenue-remaining-performance-obligation https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/royalty-revenue https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/sale-leaseback-transaction-net-book-value https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/sale-of-stock-consideration-received-on-transaction https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/sale-of-stock-number-of-shares-issued-in-transaction https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/sale-of-stock-price-per-share https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/sales-revenue-goods-net https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/sales-revenue-net https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/sec-filings-10-k https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/sec-filings-10-q https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/sec-filings-15-12g https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/sec-filings-25-nse https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/sec-filings-8-a12g https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/sec-filings-8-k https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/sec-filings-ars https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/sec-filings-ct-order https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/sec-filings-def-14a https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/sec-filings-defa14a https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/sec-filings-defm14a https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/sec-filings-pre-14a https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/sec-filings-prem14a https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/secondary-offerings-form-424a https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/secondary-offerings-form-424b2 https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/secondary-offerings-form-424b4 https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/secondary-offerings-form-424b5 https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/secondary-offerings-form-fwp https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/secondary-offerings-form-posasr https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/secondary-offerings-form-s-3asr https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/secondary-offerings-form-s-3mef https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/sga-expense https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/share-price https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/shareholders-equity https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/shares-authorized https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/shares-issued https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/shares-issued-shares-new-issues https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/stock-award-number-of-shares-authorized https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/stock-award-rsu-grants-in-period https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/stock-award-rsu-vested-in-period-total-fair-value https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/stock-based-compensation https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/stock-compensation-allocation-of-recognized-period-costs-capitalized-amount https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/stock-compensation-cash-received-from-exercise-of-stock-options https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/stock-issued-shares-issued-shares-espps https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/stock-issued-shares-issued-value-restricted-stock-award-net-of-forfeitures https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/stock-options-forfeitures-and-expirations-in-period https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/stock-options-forfeitures-and-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/stock-options-grants-in-period https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/stock-options-other-increases-decreases-in-period https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/stock-split-ratio https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/stockholders-equity-other https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/sublease-income https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/tax-reconciliation-equity-in-earnings-losses-of-unconsolidated-subsidiary https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/tax-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/tax-reconciliation-nondeductible-expense-research-and-development https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/tax-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/tax-reconciliation-tax-contingencies-foreign https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/tax-reconciliation-tax-credits-foreign https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/tax-reconciliation-tax-credits-research https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/total-assets https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/treasury-stock-acquired-average-cost-per-share https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/treasury-stock-retired-cost-method-amount https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/treasury-stock-shares https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/treasury-stock-shares-retired https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/treasury-stock-value https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/unrealized-gain-loss-on-derivatives https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/unrealized-gain-loss-on-investments https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/utb-decrease-from-prior-year-positions https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/utb-income-tax-penalties-and-interest-expense https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/utb-increase-from-settlements https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/utb-that-would-impact-effective-tax-rate https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/warrants-and-rights-outstanding https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/weighted-average-number-of-share-outstanding-basic-and-diluted https://stock.noler.com/us/stock/arena-pharmaceuticals-inc/weighted-average-number-of-shares-common-stock-subject-to-repurchase-or-cancellation